{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morgantown",
      "state": "WV",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "80006",
      "recalling_firm": "Mylan Pharmaceuticals Inc.",
      "address_1": "781 Chestnut Ridge Rd",
      "address_2": "N/A",
      "postal_code": "26505-2730",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Recalling firm distributed product to wholesalers throughout the United States, including Puerto Rico.",
      "recall_number": "D-0830-2018",
      "product_description": "PrednisoLONE  Sodium Phosphate Orally Disintegrating Tablets 15 mg, Rx Only, 48-count bottle, NDC 00378-4715-22",
      "product_quantity": "9,906 48-count bottles",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20180430",
      "center_classification_date": "20180522",
      "termination_date": "20190214",
      "report_date": "20180530",
      "code_info": "Lot #:  3082509; Exp. 08/18  3085901; Exp. 12/18"
    }
  ]
}